Clinical Trial Update: Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study [Phase 2]

View source ↗

Summary

Phase 2 single-arm trial evaluating whether hyperthermic intraperitoneal chemotherapy (HIPEC) can enhance the efficacy of immune checkpoint inhibitors in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Serous Adenocarcinoma

Snippet

Sponsor: Jing Li | Conditions: HIPEC, Ovarian Serous Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING